Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Acta Neuropathol. 2014 Nov 4;129(1):53–64. doi: 10.1007/s00401-014-1358-z

Table 1.

Demographics, pathology and genetics of case material

HpScl
n=35
Not HpScl
n=634
P-value
Demographic characteristics
  Male 17 (49%) 387 (61%) 0.197
  Age at death, years 81 (78, 85) 78 (73, 84) 0.010
Post-mortem findings
  Brain weight, grams 1000 (880, 1140) 1140 (1040, 1260) <0.001
  Braak NFT stage VI (III, VI) IV (III, V) <0.001
  Thal amyloid-β phase 5 (4, 5) 4 (3, 5) 0.003
  Lewy body subtype
    Diffuse 21 (60%) 359 (57%) 0.828
    Limbic 14 (40%) 275 (43%)
  TDP-43 positivity 35 (100%) 133 (21%) <0.001
    Type A 35/35 (100%) 66/133 (50%) <0.001
    Type B/NFT 0/35 (0%) 43/133 (32%)
    Unclassified 0/35 (0%) 24/133 (18%)
Genetic findings
  TMEM106B, C allele carriers 14/32 (44%) 370/527 (70%) 0.003
  GRN, T allele carriers 21/32 (66%) 277/527 (53%) 0.209
  APOE, ε4 allele carriers 21/32 (66%) 293/538 (54%) 0.293

All data is displayed as median (25th, 75th range), unless otherwise noted. TMEM106B rs1990622 C allele, GRN rs5848 T allele, and APOE ε4 allele carriers are displayed as number genotyped out of available cases.